Find Federal Grants
U.S. Ambassador’s President’s Emergency Plan for AIDS Relief (PEPFAR) Small Grants Program Financial Year (FY) 2022
U.S. Mission to Malawi · DOS-APSGP-FY22-001
Anti-doping Activities
Office of National Drug Control Policy · ANTI-DOPING-2022
Center for Medicare and Medicaid Services · CMS-1LI-22-001
Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-145
Agency for Health Care Research and Quality · RFA-HS-22-007
Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-132
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-025
Health Resources and Services Administration · HRSA-22-122
Population-based Surveillance of Outcomes, Needs, and Well-being of Children and Adolescents with Congenital Heart Defects
Centers for Disease Control - NCBDDD · CDC-RFA-DD22-2203
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-021
Substance Abuse and Mental Health Services Adminis · TI-22-011
Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-22-012
PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-22-013
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-024
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-022
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-021
Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
National Institutes of Health · NOT-TR-22-016
Notice of Intent to Publish a Funding Opportunity Announcement for Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed)
National Institutes of Health · NOT-RM-22-006
Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
National Institutes of Health · NOT-TR-22-017
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-023